Retinopathy of prematurity: Past, present and future

Parag K Shah1, Vishma Prabhu1, Smita S Karandikar1

  • 1Parag K Shah, Vishma Prabhu, Smita S Karandikar, Ratnesh Ranjan, Venkatapathy Narendran, Narendran Kalpana, Pediatric Retina and Ocular Oncology Department, Aravind Eye Hospital and Postgraduate Institute of Ophthalmology, Coimbatore 641014, Tamilnadu, India.

Insights

Retinopathy of prematurity (ROP) is a leading cause of preventable childhood blindness. Early screening by an ophthalmologist can prevent vision loss in preterm infants, particularly in developing nations.

Area of Science:

  • Ophthalmology
  • Neonatology
  • Public Health

Background:

  • Retinopathy of prematurity (ROP) is a vasoproliferative retinal disorder in preterm infants.
  • It is a significant, yet avoidable, cause of childhood blindness globally.
  • Increasing survival rates of preterm babies worldwide heighten the ROP burden.

Purpose of the Study:

  • To provide a comprehensive review of Retinopathy of prematurity (ROP).
  • To highlight historical, current, and future management strategies for ROP.
  • To update pediatricians on ROP knowledge for timely intervention.

Main Methods:

  • Literature review of Retinopathy of prematurity (ROP) research.
  • Analysis of historical trends and current management protocols.
  • Exploration of future strategies for ROP prevention and treatment.

Main Results:

  • ROP screening is crucial for preventing childhood blindness in preterm infants.
  • Developed nations adhere to screening guidelines, unlike developing economies with high preterm birth rates.
  • Urgent corrective steps are needed to mitigate the rising ROP burden in India and China.

Conclusions:

  • Effective ROP management requires adherence to screening protocols.
  • Addressing ROP in developing nations is critical to prevent a future blindness epidemic.
  • This review offers valuable insights for pediatricians managing ROP.